Consensus market expectations were for net income of $2.16 billion, revenue of $11.03 billion and operating income of $2.6 billion. "Operating and net income are expected to reach record levels in constant currencies for the full year, even excluding the contribution from H1N1 pandemic flu vaccine sales ... However, currency-related losses could significantly reduce growth in reported results." The firm said it expects group net sales to grow at a high-single-digit rate in local currencies, even excluding anticipated H1N1 pandemic flu vaccines sales in the fourth quarter of 2009. Full Article at MarketWatch